Profund Advisors’s Acceleron Pharma XLRN Stock Holding History

Profund Advisors’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-8,691	Closed	-$1.5M	–	1426
2021 Q3	$1.5M	Sell	8,691 -322	-4%	-$42.1K	0.05%	265
2021 Q2	$1.13M	Sell	9,013 -267	-3%	-$33.7K	0.04%	314
2021 Q1	$1.26M	Sell	9,280 -1,402	-13%	-$181K	0.05%	261
2020 Q4	$1.37M	Buy	10,682 +998	+10%	+$117K	0.06%	252
2020 Q3	$1.09M	Buy	+9,684	New	+$964K	0.06%	267

Profund Advisors's XLRN Position: Q4 2021 in Review

Profund Advisors sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 8,691 shares — an estimated $1.5M sold.

Profund Advisors first reported a position in XLRN in Q3 2020 and held it in 5 quarters. The position peaked at $1.5M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Profund Advisors reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Profund Advisors sold 8,691 Acceleron Pharma shares in Q4 2021, an estimated $1.5M.
Profund Advisors first reported a position in Acceleron Pharma in Q3 2020 and held it in 5 quarters.
Profund Advisors's Acceleron Pharma position peaked at $1.5M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Profund Advisors's 13F filing for Q4 2021, filed 8 Feb 2022.